News

The full amendment pack for Substantial Modification 07 and 08 is now available. Please access the password protected Essential Documents page of this website. The Substantial Amendment Document Pack file is located under the Regulatory/Approval Documents section of the page, under the Substantial Amendment Packs heading. This is applicable for both Comparison P and Comparison ...

From April 2026, the MRC Clinical Trials Unit will become the UCL Innovative Clinical Trials Unit. The MRC Clinical Trials Unit has received underpinning funding from the MRC since 1998. This has allowed the Unit to carry out innovative and challenging trials, meta-analyses and methodology research that have had a global impact. This funding will end in March 2026, due to chan ...

Trial Update The full amendment pack for Substantial Amendment 05 is now available. Please access the password protected area of this website. The Substantial Amendment 05 Document Pack file is located under the Essential Documents page. The team have also put together a short slide set outlining the changes which should help to reduce workload at sites. This is titled Substa ...

The full amendment pack for Substantial Amendment 03 and Non-Substantial Amendment 04 is now available. Please access the password protected Essential Documents page of this website. The Substantial Amendment 03 and Non-Substantial Amendment 04 Document Pack file is located under the Regulatory/Approval Documents section of the page, under the Substantial Amendment Packs headin ...

The ESMO Congress serves as a globally influential platform in oncology, bringing together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world. The STAMPEDE2 trial will be presented at the event, with each of its three comparisons detailed in a set of posters. Please find links to these posters below: ESMO STA ...